Case Evaluation
Over $150 Million Collected for Plantiffs in 2011


Date posted: 4/13/2012

Surprising news came this week that the maker of Pradaxa, Boehringer Ingelheim, is having a banner year for sales, and a large part of that id due to the controversial anticoagulant drug Pradaxa itself.

The news came as a shock to many given the fact that the FDA launched an investigation into the safety of Pradaxa in December, 2011, after receiving hundreds of reports of injury or death from patients experiencing uncontrollable internal bleeding.

« prev 1 2 next »
Facebook Twitter Youtube